Boeing statement regarding CST-100 Starliner pad abort test

Boeing issued the following statement regarding the successful CST-100 Starliner pad abort test.

Today’s pad abort test was a milestone achievement for our CST-100 Starliner team, for NASA, and for American human spaceflight. We will review the data to determine how all of the systems performed, including the parachute deployment sequence. We did have a deployment anomaly, not a parachute failure. It’s too early to determine why all three main parachutes did not deploy, however, having two of three deploy successfully is acceptable for the test parameters and crew safety. At this time we don’t expect any impact to our scheduled Dec. 17 Orbital Flight Test. Going forward we will do everything needed to ensure safe orbital flights with crew.

Source: The Boeing Company (NYSE: BA)
Date: Nov 4, 2019